Stockwatch: Is Mallinckrodt Deep Value Pharma?

Litigation, Depressed Sales and Bankruptcy Warning Place Stock In Value Investing Territory

 
• By Andy Smith
  
StockWatch_Andy-Smith_V2_1200.jpg
ANDY SMITH OFFERS A LIFE SCIENCE INVESTOR'S PERSPECTIVE ON BIOPHARMA BUSINESS
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip